Untangling interactions between Bitis vipers and their prey using coagulotoxicity against diverse vertebrate plasmas. (September 2022)

• Record Type: Journal Article
• Authors: Youngman, Nicholas J.; Llinas, Joshua; Haworth, Mark; Gillett, Amber; Jones, Lee; Walker, Andrew A.; Fry, Bryan G.
• Is Part Of: Toxicon. Volume 216(2022)
• Page Start: 37
• Page End: 44
• Publication Date: 2022-09
• Subjects: Bitis -- Coagulotoxicity -- Diet -- Fibrinogen -- Prey specificity; Toxins -- Periodicals; Venom -- Periodicals; 615.9
• DOI: 10.1016/j.toxicon.2022.06.012
• Languages: English
• ISSNs: 0041-0101

Abstract

Abstract: Venom is a key evolutionary innovation which plays a primary role in prey subjugation by venomous snakes. However, while there is a growing body of literature indicating the composition and activity of snake venoms is under strong natural selection driven by differences in prey physiology, the majority of studies have historically focussed on the activity of snake venoms with regards only towards human or mammalian physiologies. This study aimed to use clotting assays measuring both time and strength of clotting to characterise the coagulotoxic activity of venoms from a taxonomically, morphologically, and ecologically diverse range of Bitis spp. of viperid snakes upon the plasma of model species: amphibian (Cane Toad, Rhinella marina ); lizard (Blue-tongue Skink, Tiliqua scincoides ); avian (Domestic Chicken, Gallus gallus ); and rodent (Brown Rat, Rattus norvegicus ). Significant variation in coagulotoxic activity across the different plasmas was observed between species and compared to the known affects upon human plasma. Bitis caudalis was notable in being active on all four plasmas, but in extremely divergent manners: accelerating clotting times and producing strong, stable clots upon amphibian plasma (consistent with true procoagulation); accelerating clotting time but producing weak, unstable clots upon lizard plasma (consistent with pseudo-procoagulation); delaying avian clotting time beyond machine maximum reading time (strong anticoagulation consistent with either inhibition of clotting enzymes or total destruction of fibrinogen, or both); and delaying clotting of rodent plasma (consistent with inhibition of clotting enzymes) and with only weak clots formed (consistent with destruction of fibrinogen). In contrast, the sister species B. peringueyi and B. schneideri displayed activity only upon the lizard plasma, slightly accelerating the clotting times to produce weak, unstable clots (consistent with pseudo-procoagulation). The other dwarf species, B. cornuta, displayed strong anticoagulation upon avian and rodent plasmas, delaying clotting beyond the machine maximum reading time (strong anticoagulation consistent with either inhibition of clotting enzymes or total destruction of fibrinogen, or both). In contrast, the giant species studied ( B. gabonica ) showed only a very weak pseudo-procoagulant activity upon lizard plasma. The wide range of variation seen within this study highlights the importance of studying venom activity on relevant models when making conclusions about the ecological role of venoms and the extreme limitation in extrapolating animal results to predict potential human clinical effects. Graphical abstract: Image 1 Highlights: Bitis caudalis displays highly differential coagulotoxicity upon vertebrate plasmas. B. caudalis venom shows coagulotoxicity upon amphibian, avian, lizard and rodent plasma. Bitis peringueyi and B. schneideri exert pseudo-procoagulant activity upon lizard plasma. Venom activity is driven by and variable based upon differences in prey physiology.